Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. (Q54740183)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24134219

Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24134219

0 references

0 references

corrigendum / erratum

Risks of neurological and immune-related diseases, including narcolepsy, after vaccination with Pandemrix: a population- and registry-based cohort study with over 2 years of follow-up.

0 references

5

object named as

T Olsson

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

author name string

I Persson

1

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24134219

F Granath

2

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24134219

J Askling

3

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24134219

J F Ludvigsson

4

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24134219

N Feltelius

6

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24134219

language of work or name

0 references

publication date

10 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24134219

Journal of Internal Medicine

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24134219

275

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24134219

2

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24134219

172-190

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24134219

AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12150

21 January 2018

Single dose vaccination with AS03-adjuvanted H5N1 vaccines in a randomized trial induces strong and broad immune responsiveness to booster vaccination in adults.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12150

21 January 2018

Autoimmunity induced by adjuvant hydrocarbon oil components of vaccine.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12150

21 January 2018

The Guillain-Barré syndrome and the 1992-1993 and 1993-1994 influenza vaccines.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12150

21 January 2018

Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12150

21 January 2018

Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12150

21 January 2018

Risk of convulsions in children after monovalent H1N1 (2009) and trivalent influenza vaccines: a database study

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12150

21 January 2018

Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12150

21 January 2018

Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12150

21 January 2018

H1N1 vaccines in a large observational cohort of patients with inflammatory bowel disease treated with immunomodulators and biological therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12150

21 January 2018

Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12150

21 January 2018

Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12150

21 January 2018

No serological evidence of influenza A H1N1pdm09 virus infection as a contributing factor in childhood narcolepsy after Pandemrix vaccination campaign in Finland.

1 reference

https://api.crossref.org/works/10.1111%2FJOIM.12150

21 January 2018

Identifiers

10.1111/JOIM.12150

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24134219

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/24134219

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54740183&oldid=1511516658"